{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T01:17:36Z","timestamp":1747185456494,"version":"3.40.5"},"reference-count":34,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Lab Hematology"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Glutathione S\u2010transferase (GST) gene deletion or polymorphic sequence variations lead to decreased enzyme activity that influences susceptibility and response to tyrosine kinase inhibitors in chronic myeloid leukemia (CML). We aimed to analyze relation of different GST gene sequence variants with susceptibility and response to Imatinib in CML.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and Methods<\/jats:title><jats:p>A total of 150\u00a0CML cases and equal number of age and gender matched healthy controls were genotyped for five <jats:italic>GST<\/jats:italic> polymorphisms by multiplex\u2010PCR and PCR\u2010RFLP techniques. <jats:italic>BCR\u2010ABL1<\/jats:italic> transcripts were quantified by quantitative Real Time PCR (qRT\u2010PCR).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p><jats:italic>GSTT1<\/jats:italic>, <jats:italic>GSTO1,<\/jats:italic> and <jats:italic>GSTO2<\/jats:italic> SNPs revealed no association, while as <jats:italic>GSTM1<\/jats:italic><jats:sub>null<\/jats:sub> genotype was observed to protect against the development of CML (OR\u00a0=\u00a00.53, <jats:italic>P<\/jats:italic>\u00a0=\u00a0.01). <jats:italic>GSTP1<\/jats:italic> variant genotypes AG (OR\u00a0=\u00a02.1, <jats:italic>P<\/jats:italic>\u00a0=\u00a0.003) and GG (OR\u00a0=\u00a05.6, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a0.001), significantly associated with increased risk of CML. Combined genotype analysis showed protective impact of <jats:italic>GSTT1<\/jats:italic><jats:sub>present<\/jats:sub>\/<jats:italic>GSTM1<\/jats:italic><jats:sub>null<\/jats:sub> (OR\u00a0=\u00a00.44, <jats:italic>P<\/jats:italic>\u00a0=\u00a0.003) while as <jats:italic>GSTT1<\/jats:italic><jats:sub>present<\/jats:sub>\/<jats:italic>GSTP1\u2010<\/jats:italic>GG (OR\u00a0=\u00a06.92, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a0.001) and <jats:italic>GSTM1<\/jats:italic><jats:sub>present<\/jats:sub>\/<jats:italic>GSTP1\u2010<\/jats:italic>GG (OR\u00a0=\u00a06.33, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a0.001), significantly increased CML risk. <jats:italic>GSTM1<\/jats:italic><jats:sub>null<\/jats:sub> genotype individually and in combination with <jats:italic>GSTT1<\/jats:italic><jats:sub>present<\/jats:sub> associated with superior rate of major molecular response (MMR) and event free survival (EFS) (log\u2010rank <jats:italic>P<\/jats:italic>\u00a0=\u00a0.029). <jats:italic>GSTO2\u2010<\/jats:italic>AG+GG genotype associated with significantly inferior MMR rates at 3, 6, and 12\u00a0months. Also, patients with <jats:italic>GSTO2\u2010<\/jats:italic>GG genotype showed significantly reduced EFS (log\u2010rank <jats:italic>P<\/jats:italic>\u00a0=\u00a0.025). Multivariate analysis confirmed <jats:italic>GSTM1<\/jats:italic><jats:sub>null<\/jats:sub> as a better (HR:0.19, <jats:italic>P<\/jats:italic>\u00a0=\u00a0.029) and <jats:italic>GSTO2<\/jats:italic>\u2010GG genotype as an independent poor prognostic factor (HR:2.29, <jats:italic>P<\/jats:italic>\u00a0=\u00a0.037).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p><jats:italic>GSTM1<\/jats:italic><jats:sub>null<\/jats:sub> genotype seems to have a better prognostic role while <jats:italic>GSTP1<\/jats:italic> variants significantly increase CML risk. Also, results support a correlation between disease outcome and GSTO2 polymorphism.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ijlh.13471","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T14:00:44Z","timestamp":1611151244000},"page":"1000-1008","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glutathione S\u2010transferase gene polymorphic sequence variations: Association with risk and response to Imatinib among Chronic Myeloid Leukemia patients of Kashmir"],"prefix":"10.1111","volume":"43","author":[{"given":"Shahid M.","family":"Baba","sequence":"first","affiliation":[{"name":"Department of Immunology and Molecular Medicine Sher\u2010I\u2010Kashmir Institute of Medical Sciences Srinagar India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2481-1268","authenticated-orcid":false,"given":"Zafar A.","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Immunology and Molecular Medicine Sher\u2010I\u2010Kashmir Institute of Medical Sciences Srinagar India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arshad A.","family":"Pandith","sequence":"additional","affiliation":[{"name":"Advanced Centre for Human Genetics Sher\u2010I\u2010Kashmir Institute of Medical Sciences Srinagar India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajad A.","family":"Geelani","sequence":"additional","affiliation":[{"name":"Department of Clinical Hematology Sher\u2010I\u2010Kashmir Institute of Medical Sciences Srinagar India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad M.","family":"Mir","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences University of Bisha Bisha Kingdom of Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javid R.","family":"Bhat","sequence":"additional","affiliation":[{"name":"Department of Clinical Hematology Sher\u2010I\u2010Kashmir Institute of Medical Sciences Srinagar India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaz","family":"Gul","sequence":"additional","affiliation":[{"name":"Department of Immunology and Molecular Medicine Sher\u2010I\u2010Kashmir Institute of Medical Sciences Srinagar India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gul M.","family":"Bhat","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Sher\u2010I\u2010Kashmir Institute of Medical Sciences Srinagar India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,1,20]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.10.3343"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-169110"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-326025"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-008-0100-y"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-273979"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.04.003"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2015.11"},{"key":"e_1_2_10_9_1","first-page":"6","article-title":"CAT, GPX1, Mn SOD, GSTM1, GSTT1, and GSTP1 genetic polymorphisms in chronic myeloid leukemia: a case\u2010control study","author":"Banescu C","year":"2014","journal-title":"Oxid Med Cell Longev"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2015.08.034"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S169833"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206940"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-5107(01)00206-8"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-1810-7"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi035832z"},{"key":"e_1_2_10_16_1","first-page":"416","article-title":"GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response","volume":"4","author":"Weicha N","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.1018"},{"key":"e_1_2_10_18_1","first-page":"107","article-title":"Genetic alterations in chromosome 10q24.3 and glutathione S\u2010transferase Omega 2 gene polymorphism in ovarian cancer","volume":"25","author":"Pongstaporn W","year":"2006","journal-title":"J Exp Clin Cancer Res"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-008-0501-4"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-006-0099-3"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12332"},{"key":"e_1_2_10_22_1","article-title":"Impact of Oxidative Changes and Possible Effects of Genetics Polymorphisms of Glutathione S\u2010Transferase in Diabetics Patients with Complications. Glutathione in Health and Disease. Pinar Erkekoglu and BelmaKocer\u2010Gumusel","author":"Anjos LRB","year":"2018","journal-title":"Intech Open"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph13040379"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12041-017-0819-2"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401592"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-501569"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.717"},{"key":"e_1_2_10_28_1","first-page":"12","article-title":"CYP1A1, GST gene polymorphisms and risk of chronic myeloid leukaemia","volume":"138","author":"Taspinar M","year":"2008","journal-title":"Swiss Med Wkly"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.4.1222.004k20_1222_1228"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)01290-6"},{"key":"e_1_2_10_31_1","first-page":"461","article-title":"Association of the GSTP1 gene (Ile105Val) polymorphism with chronic myeloid leukemia","volume":"11","author":"Sailaja K","year":"2010","journal-title":"Asian Pac. J. Cancer Prev"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.176"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/09723757.2012.11886176"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)03066-8"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200303000-00003"}],"container-title":["International Journal of Laboratory Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.13471","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ijlh.13471","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.13471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T22:12:17Z","timestamp":1693347137000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijlh.13471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1111\/ijlh.13471"],"URL":"https:\/\/doi.org\/10.1111\/ijlh.13471","archive":["Portico"],"relation":{},"ISSN":["1751-5521","1751-553X"],"issn-type":[{"type":"print","value":"1751-5521"},{"type":"electronic","value":"1751-553X"}],"subject":[],"published":{"date-parts":[[2021,1,20]]},"assertion":[{"value":"2020-10-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}